首页> 外文期刊>RSC Advances >Synthesis and investigation of water-soluble anticoagulant warfarin/ferulic acid grafted rare earth oxide nanoparticle materials
【24h】

Synthesis and investigation of water-soluble anticoagulant warfarin/ferulic acid grafted rare earth oxide nanoparticle materials

机译:水溶性抗凝华法林/阿魏酸接枝稀土氧化物纳米粒子材料的合成与研究

获取原文
获取原文并翻译 | 示例
           

摘要

To overcome the poor solubility of anticoagulant nano-rare earth (RE) oxides and warfarin/ferulic acid in water, two series of water-soluble anticoagulant materials, RE2O3-TDI-PEG-warfarin and RE2O3-TDI-PEG-ferulic acid (TDI = toluene 2,4-diisocyanate, RE = La, Eu, Nd, Sc, Sm, Dy), were prepared via a grafting method. The novel materials were characterized by IR, TG, XRD, SEM, TEM, H-1 and C-13 NRM and particle size tests. The results confirmed that warfarin and ferulic acid were successfully modified onto the surfaces of the rare earth nano-oxides. The anticoagulant properties were evaluated on the basis of coagulation time (CT), recalcification time (RT), activated partial thromboplastin time (APTT) and prothrombin time (PT). It was demonstrated that the novel hybrid materials have better cell compatibility and anticoagulant action than that of warfarin sodium or ferulic acid, due to the increased solubility (>10 mg mL(-1)) in water and synergy between nano-RE2O3 and warfarin/ferulic acid. It was also found that the anticoagulant time of the hybrid materials depends on the concentration i.e., the higher the concentration of hybrid materials, the longer the anticoagulant time. Additionally, Sc2O3-TDI-PEG-warfarin and Sc2O3-TDI-PEG-ferulic acid exhibited the best anticoagulant properties, which indicate potential application in the medicinal area. These results also provide the opportunity for the development of anticoagulant complexes and the potential for application in other related fields.
机译:为了克服抗凝性纳米稀土(RE)氧化物和华法林/阿魏酸在水中的不良溶解性,使用了两类水溶性抗凝材料:RE2O3-TDI-PEG-warfarin和RE2O3-TDI-PEG-阿魏酸(TDI)通过接枝方法制备甲苯= 2,4-二异氰酸酯,RE = La,Eu,Nd,Sc,Sm,Dy)。通过IR,TG,XRD,SEM,TEM,H-1和C-13 NRM以及粒度测试对新型材料进行了表征。结果证实华法林和阿魏酸被成功修饰到稀土纳米氧化物的表面上。根据凝血时间(CT),重钙化时间(RT),活化的部分凝血活酶时间(APTT)和凝血酶原时间(PT)评估抗凝血性能。结果表明,新型杂化材料比华法林钠或阿魏酸具有更好的细胞相容性和抗凝作用,这是由于在水中的溶解度增加(> 10 mg mL(-1))以及纳米RE2O3与华法林/阿魏酸。还发现杂化材料的抗凝时间取决于浓度,即,杂化材料的浓度越高,抗凝时间越长。另外,Sc2O3-TDI-PEG-华法林和Sc2O3-TDI-PEG-阿魏酸显示出最佳的抗凝性能,表明其在医学领域的潜在应用。这些结果也为开发抗凝复合物提供了机会,并有可能在其他相关领域中应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号